GA NCORP

TRIALS & PROVIDERS

Menu

NCORP Trials

Cancer Type = Testicular Cancer

1.
Accelerated or Standard BEP Chemotherapy in Treating Patients with Intermediate or Poor-Risk Metastatic Germ Cell Tumors
Cancer Type
Germ Cell Tumor, Testicular Cancer
NCI ID
NCT02582697
Protocol IDs
AGCT1532 (primary)
AGCT1532
NCI-2017-00559
Treatment Sites (2)
Atrium Health Navicent
Macon
Oncology Research Nurse
4786332152
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
2.
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients with Germ Cell Tumors
Cancer Type
Germ Cell Tumor, Testicular Cancer
NCI ID
NCT03067181
Protocol IDs
AGCT1531 (primary)
AGCT1531
NCI-2017-00178
AGCT1531
Treatment Sites (2)
Atrium Health Navicent
Macon
Oncology Research Nurse
4786332152
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
3.
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients with High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Cancer Type
Leukemia, Testicular Cancer
NCI ID
NCT03959085
Protocol IDs
AALL1732 (primary)
AALL1732
NCI-2019-02845
Treatment Sites (3)
Atrium Health Navicent
Macon
Oncology Research Nurse
4786332152
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
For a complete listing of all trials matching your criteria in Georgia, please visit GeorgiaCancerInfo.org
1-3 of 3 Trials
CALL EMAIL

Copyright © 2015, Georgia NCI Community Oncology Research Program. All Rights Reserved.
Powered by GeorgiaCancerInfo.org
Website Design & Development by Peachtree Solutions.